PARENTERAL DRUGS (INDIA) LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.9 INR | +1.75% |
|
-.--% | -.--% |
| 2023 | PSBs Reportedly Shelve Deal to Sell Drug Company Loans to NARCL | CI |
| 2023 | NARCL Reportedly Offers to Buy INR 11,000 million Loans of Parenteral Drugs | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 816B | ||||||
| 634B | ||||||
| 351B | - | - | - | - | ||
| 323B | ||||||
| 293B |
